NEE
90.2
+0.65%↑
SO
93.72
+0.24%↑
CEG.US
289.97
+2.82%↑
DUK
127.31
+0.28%↑
AEP
128.02
+1.93%↑
NEE
90.2
+0.65%↑
SO
93.72
+0.24%↑
CEG.US
289.97
+2.82%↑
DUK
127.31
+0.28%↑
AEP
128.02
+1.93%↑
NEE
90.2
+0.65%↑
SO
93.72
+0.24%↑
CEG.US
289.97
+2.82%↑
DUK
127.31
+0.28%↑
AEP
128.02
+1.93%↑
NEE
90.2
+0.65%↑
SO
93.72
+0.24%↑
CEG.US
289.97
+2.82%↑
DUK
127.31
+0.28%↑
AEP
128.02
+1.93%↑
NEE
90.2
+0.65%↑
SO
93.72
+0.24%↑
CEG.US
289.97
+2.82%↑
DUK
127.31
+0.28%↑
AEP
128.02
+1.93%↑
24h
Aktuell
Min
0.18
Max
0.3
Einkommen | 944K -300K |
|---|---|
Verkäufe | 29K 91K |
EPS | -0.08 |
Gewinnspanne | -330.736 |
Angestellte | 14 |
EBITDA | 802K -181K |
Nächstes Ergebnis | 26. März 2026 |
|---|
Marktkapitalisierung | 899K 3.9M |
|---|---|
Vorheriger Eröffnungskurs | 4.57 |
Vorheriger Schlusskurs | 0.22 |
By Trading Central
Vertrauen
Bearish Evidence
0.6205 / 0.6505 Unterstützung & Widerstand
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
23. März 2026, 23:47 UTC
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update
DJ
Lesen
23. März 2026, 22:55 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
DJ
Lesen
23. März 2026, 21:51 UTC
Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update
DJ
Lesen
23. März 2026, 23:59 UTC
Global Equities Roundup: Market Talk
DJ
Lesen
23. März 2026, 23:59 UTC
Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk
DJ
Lesen
23. März 2026, 23:50 UTC
Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk
DJ
Lesen
23. März 2026, 23:37 UTC
Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk
DJ
Lesen
23. März 2026, 22:42 UTC
Global Equities Roundup: Market Talk
DJ
Lesen
23. März 2026, 22:42 UTC
Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk
DJ
Lesen
23. März 2026, 22:40 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18B
DJ
Lesen
23. März 2026, 22:23 UTC
Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk
DJ
Lesen
23. März 2026, 22:22 UTC
Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease
DJ
Lesen
23. März 2026, 22:21 UTC
Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales
DJ
Lesen
23. März 2026, 22:21 UTC
Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China
DJ
Lesen
23. März 2026, 22:20 UTC
Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD
DJ
Lesen
23. März 2026, 22:20 UTC
Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD
DJ
Lesen
23. März 2026, 22:19 UTC
Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders
DJ
Lesen
23. März 2026, 22:19 UTC
Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets
DJ
Lesen
23. März 2026, 22:18 UTC
Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD
DJ
Lesen
23. März 2026, 22:15 UTC
Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD
DJ
Lesen
23. März 2026, 22:08 UTC
Ebos Needs to Reset Its Gearing Targets -- Market Talk
DJ
Lesen
23. März 2026, 21:42 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Lesen
23. März 2026, 21:42 UTC
RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk
DJ
Lesen
23. März 2026, 21:32 UTC
WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK
DJ
Lesen
23. März 2026, 21:32 UTC
WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK
DJ
Lesen
23. März 2026, 21:32 UTC
WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK
DJ
Lesen
23. März 2026, 21:10 UTC
Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com
DJ
Lesen
23. März 2026, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Lesen
23. März 2026, 20:50 UTC
Health Care Roundup: Market Talk
DJ
Lesen
23. März 2026, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Lesen
Kursveränderung
By Trading Central
Kurzfristig
Bearish Evidence
Recent bearish events outweigh bullish events.
Mittelfristig
Bearish Evidence
Recent bearish events outweigh bullish events.
Langfristig
Neutral Evidence
The bullish and bearish events are balanced.
Vertriebs- und Verwaltungskosten
Betriebsaufwand
Gewinn vor Steuern
Verkäufe
Umsatzkosten
Bruttogewinn aus dem Verkauf
Zinsaufwand für Schulden
EBITDA
Betriebsergebnis
$